Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection
AstraZeneca vaccine effective against UK variant: Oxford University
5 February 2021New drug targets for childhood cancer neuroblastoma identified
5 February 2021Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection
SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.
